Mark Ganner
Impact in
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
Papers in
-
- Antimicrobial Resistance in Staphylococcus 23
- Clostridium difficile and Clostridium perfringens research 4
- Viral gastroenteritis research and epidemiology 2
-
- Bacterial Identification and Susceptibility Testing 10
- Co-authors
- Angela Kearns (14 shared papers)B. Cookson (8 shared papers)Anne M. Holmes (2 shared papers)Matthew J. Ellington (7 shared papers)Taylor L. Pitt (1 shared paper)Meghan Warner (5 shared papers)Robert L. Hill (7 shared papers)Claire Perry (4 shared papers)
- Journals
- Journal of Clinical Microbiology (5 papers)Journal of Antimicrobial Chemotherapy (4 papers)Clinical Microbiology and Infection (4 papers)Journal of Hospital Infection (3 papers)Journal of Medical Microbiology (2 papers)
- Partner nations
- United KingdomNepalItaly
In The Last Decade
Mark Ganner
27 papers receiving 1.1k citations
Mark Ganner's Hit Papers
Peers
Comparison fields: 5 of 79
- Clinical Biochemistry 394
- Infectious Diseases 892
- Public Health, Environmental and Occupational Health 281
- Microbiology 55
- Molecular Medicine 37
Countries citing papers authored by Mark Ganner
This map shows the geographic impact of Mark Ganner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ganner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ganner more than expected).
Fields of papers citing papers by Mark Ganner
This network shows the impact of papers produced by Mark Ganner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ganner. The network helps show where Mark Ganner may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ganner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 347 | |
| 2 | 2010 | 74 | |
| 3 | Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenes Hit paper breakdown → | 2024 | 74 |
| 4 | 2009 | 70 | |
| 5 | 2006 | 69 | |
| 6 | 2007 | 69 | |
| 7 | 1994 | 68 | |
| 8 | 2004 | 48 | |
| 9 | 2009 | 47 | |
| 10 | 2007 | 45 | |
| 11 | 2000 | 37 | |
| 12 | 2010 | 27 | |
| 13 | 2010 | 26 | |
| 14 | 2009 | 22 | |
| 15 | 2009 | 20 | |
| 16 | 2009 | 20 | |
| 17 | 2012 | 14 | |
| 18 | 2002 | 12 | |
| 19 | 1994 | 11 | |
| 20 | 1993 | 9 |
About Mark Ganner
Mark Ganner is a scholar working on Infectious Diseases, Clinical Biochemistry, Public Health, Environmental and Occupational Health, Molecular Biology and Ecology, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (23 papers), Bacterial Identification and Susceptibility Testing (10 papers), Bacterial biofilms and quorum sensing (7 papers), Streptococcal Infections and Treatments (7 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Bacteriophages and microbial interactions (3 papers), Viral gastroenteritis research and epidemiology (2 papers) and Genomics and Phylogenetic Studies (2 papers). The work is most often cited by research in Clinical Biochemistry (394 citations), Infectious Diseases (892 citations), Public Health, Environmental and Occupational Health (281 citations), Microbiology (55 citations) and Molecular Medicine (37 citations). Mark Ganner has collaborated with scholars based in United Kingdom, Nepal and Italy. Frequent co-authors include Angela Kearns, B. Cookson, Anne M. Holmes, Matthew J. Ellington, Taylor L. Pitt, Meghan Warner, Robert L. Hill, Claire Perry, Eve Boakes and M. Costas. Their work appears in journals such as Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection, Journal of Hospital Infection and Journal of Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.